Pulmonary Hypertension Association (PHA) has selected Matt J. Granato as their next President and CEO. Launched in 1991 by patients and a caregiver, the group’s goal is to build a community of support, as well as to foster education and support research into pulmonary hypertension (PH). Granato will serve as the third person in the role of President and CEO for the PHA.
Most recently Granato served as the CEO of the Society for Maternal-Fetal Medicine (SMFM), which focuses on helping people with high-risk pregnancies. There, he worked to meet the needs of both healthcare providers and their patients.
Granato succeeds Brad A. Wong as CEO of PHA, whose term began in 2016 and expires at year’s end. Under Wong’s direction, the PHA continued to promote patient care and research, raise awareness of the disease, and amplify the voice of people with PH.
Loading ...